61334 Federal Register / Vol. 65, No. 201 / Tuesday, October 17, 2000 / Notices

FEDERAL RESERVE SYSTEM

Change in Bank Control Notices;

Acquisitions of Shares of Banks or

Bank Holding Companies

The notificants listed below have

applied under the Change in Bank

Control Act (12 U.S.C. 1817(j)) and

225.41 of the Board’s Regulation Y (12

CFR 225.41) to acquire a bank or bank

holding company. The factors that are

considered in acting on the notices are

set forth in paragraph 7 of the Act (12

U.S.C. 1817(j)(7)).

The notices are available for

immediate inspection at the Federal

Reserve Bank indicated. The notices

also will be available for inspection at

the offices of the Board of Governors.

Interested persons may express their

views in writing to the Reserve Bank

indicated for that notice or to the offices

of the Board of Governors. Comments

must be received not later than October

31, 2000.

A. Federal Reserve Bank of Dallas

(W. Arthur Tribble, Vice President) 2200

North Pearl Street, Dallas, Texas 75201–

2272:

1. Gene Allen Van Meter, Beaumont,

Texas; Barbara Van Meter, Beaumont,

Texas; Gene Allen Van Meter, Jr. ,

Lumberton, Texas; and Gary Stephen

Van Meter, Beaumont, Texas all to

acquire additional voting shares of

Lamar Bancshares, Inc., Beaumont,

Texas, and thereby indirectly acquire

additional voting shares of Lamar Bank,

Beaumont, Texas.

Board of Governors of the Federal Reserve

System, October 11, 2000.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 00–26542 Filed 10–16–00; 8:45 am]

BILLING CODE 6210–01–P

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies;

Correction

This notice corrects a notice (FR Doc.

00–25132) published on page 58771 of

the issue for Monday, October 2, 2000.

Under the Federal Reserve Bank of

Kansas City heading, the entry for Sturm

Financial Group, Inc., Denver, Colorado,

is revised to read as follows:

A. Federal Reserve Bank of Kansas

City (D. Michael Manies, Assistant Vice

President) 925 Grand Avenue, Kansas

City, Missouri 64198–0001:

1. Sturm Financial Group, Inc.,

Denver, Colorado; to become a bank

holding company by acquiring 100

percent of the voting shares of Sturm

Banks of Colorado, Inc., Denver,

Colorado, and thereby indirectly acquire

Bank of Cherry Creek N.A., Boulder,

Colorado, Bank of Cherry Creek N.A.,

Denver, Colorado, Mesa National Bank,

Grand Junction, Colorado, Western

National Bank of Colorado, Colorado

Springs, Colorado; Sturm Banks of

Wyoming, Inc., Denver, Colorado, and

thereby indirectly acquire American

National Bank of Cheyenne, Cheyenne,

Wyoming, Wyoming Bank & Trust

Company N.A., Buffalo, Wyoming,

Stockgrowers State Bank N.A., Worland,

Wyoming, Bank of Laramie N.A.,

Laramie, Wyoming; and Sturm Banks of

Kansas City, Inc., Denver, Colorado, and

thereby indirectly acquire Premier Bank,

Lenexa, Kansas.

In connection with this application,

Applicant also has applied to acquire

Community First Data Services, Inc.,

Cheyenne, Wyoming, and thereby

engage in data processing activities,

pursuant to 225.28(b)(14) of Regulation

Y.

In addition to this application, Sturm

Financial Group, Inc., Denver, Colorado

and Sturm Banks of Kansas City, Inc.,

Denver, Colorado also have applied to

engage in lending activities, pursuant to

225.28(b)(1) of Regulation Y.

Comments on this application must

be received by October 26, 2000.

Board of Governors of the Federal Reserve

System, October 11, 2000.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 00–26541 Filed 10–16–00; 8:45 am]

BILLING CODE 6210–01–P

FEDERAL RESERVE SYSTEM

Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Board of

Governors of the Federal Reserve

System.

TIME AND DATE: 11 a.m., Monday,

October 23, 2000.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, 20th and C

Streets, NW., Washington, DC 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments,

reassignments, and salary actions)

involving individual Federal Reserve

System employees.

2. Any items carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Lynn S. Fox, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.federalreserve.gov for an

electronic announcement that not only

lists applications, but also indicates

procedural and other information about

the meeting.

Dated: October 13, 2000.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 00–26784 Filed 10–13–00; 3:25 pm]

BILLING CODE 6210–01–P

FEDERAL TRADE COMMISSION

Agency Information Collection

Activities; Proposed Collection;

Comment Request

AGENCY: Federal Trade Commission

(FTC).

ACTION: Notice.

SUMMARY: The FTC has investigated

several cases in which manufacturers of

pharmaceutical drug products and

generic competitors have allegedly

entered into anticompetitive agreements

to delay generic entry. These cases may

foreshadow similar anticompetitive

agreements that may eliminate the

benefits to consumers of generic drug

competition. The FTC is considering a

study to investigate how generic drug

competition has developed in light of

certain provisions in the Hatch-Waxman

Act that govern entry of generic drug

products. Before investigating whether

these provisions of the Hatch-Waxman

Act encourage generic competition or

facilitate the use of anticompetitive

strategies, the FTC seeks public

comments on its proposed information

requests to firms in the pharmaceutical

drug industry. Comments will be

considered before the FTC submits a

request for Office of Management and

Budget (OMB) review under the

Paperwork Reduction Act.

DATES: Comments must be submitted on

or before December 18, 2000.

ADDRESSES: Send written comments to

Secretary, Federal Trade Commission,

Room H–159, 600 Pennsylvania

Avenue, NW., Washington, DC 20580,

or by e-mail to <generic

drugstudy@ftc.gov>. The submissions

should include the submitter’s name,

address, telephone number, and, if

available, FAX number and e-mail

address. All submissions should be

captioned ‘‘Generic Drug Study—FTC

File No. V000014.’’